MassMutual Private Wealth & Trust’s Krystal Biotech KRYS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.5K	Buy	90 +4	+5%	+$1.2K	﹤0.01%	931
2026 Q1	$22.2K	Buy	86 +1	+1%	+$266	﹤0.01%	1049
2025 Q4	$21K	Buy	85 +13	+18%	+$2.74K	﹤0.01%	1095
2025 Q3	$12.7K	Buy	72 +12	+20%	+$1.8K	﹤0.01%	1297
2025 Q2	$8.25K	Buy	60 +8	+15%	+$1.18K	﹤0.01%	1438
2025 Q1	$9.38K	Buy	52 +26	+100%	+$4.37K	﹤0.01%	1324
2024 Q4	$4.07K	Sell	26 -3	-10%	-$532	﹤0.01%	1602
2024 Q3	$5.28K	Hold	29	–	–	﹤0.01%	1363
2024 Q2	$5.33K	Buy	29 +12	+71%	+$2.02K	﹤0.01%	1288
2024 Q1	$3.02K	Hold	17	–	–	﹤0.01%	1420
2023 Q4	$2.11K	Hold	17	–	–	﹤0.01%	1484
2023 Q3	$1.97K	Hold	17	–	–	﹤0.01%	1513
2023 Q2	$2K	Hold	17	–	–	﹤0.01%	1468
2023 Q1	$1.36K	Buy	17 +6	+55%	+$471	﹤0.01%	1522
2022 Q4	$1K	Hold	11	–	–	﹤0.01%	1476
2022 Q3	$1K	Hold	11	–	–	﹤0.01%	1453
2022 Q2	$1K	Hold	11	–	–	﹤0.01%	1337
2022 Q1	$1K	Buy	+11	New	+$687	﹤0.01%	1356

Other funds holding KRYS

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

MassMutual Private Wealth & Trust's KRYS Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Krystal Biotech (KRYS) stake by 4.7% in Q2 2026, buying an estimated $1.2K and bringing the position to 90 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #931.

MassMutual Private Wealth & Trust first reported a position in KRYS in Q1 2022 and has held it in 18 quarters since. 129 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

MassMutual Private Wealth & Trust held 90 shares of Krystal Biotech worth $33.5K as of Q2 2026.
MassMutual Private Wealth & Trust bought 4 Krystal Biotech shares in Q2 2026, an estimated $1.2K.
Krystal Biotech made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #931 holding.
MassMutual Private Wealth & Trust first reported a position in Krystal Biotech in Q1 2022 and has held it in 18 quarters since.
129 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.